VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
34 hedge funds and large institutions have $10.8M invested in Vincerx Pharma, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.46M | |
| 2 | +$42K | |
| 3 | +$17.7K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17.4K |
| 5 |
SRC
Sage Rhino Capital
Menlo Park,
California
|
+$16.6K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$506K | |
| 3 | -$493K | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$293K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$49.4K |